There is ready a publicly traded stock that does this: candeltx.com
candeltx.com
Candel Therapeutics | Viral Immunotherapy for Cancer
Clinical-stage biotech developing viral immunotherapy platforms for solid tumors. Phase 3 results in prostate cancer, active trials in lung and brain cancer.